Sign in

CIK 0001420720

  • Non-accelerated filer
  • Smaller reporting company
Ticker
IBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
262797813
Phone
+1 302-355-0650
Business address
600 MADISON AVENUE, SUITE 1601, NEW YORK, NY, 10022-1737
Former names
iBio, Inc., iBioPharma, Inc., InB:Biotechnologies, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-04-24 Brenner Martin See Remarks Sale −4,382 $1.20 $5K 261,777
2023-03-31 Brenner Martin See Remarks Grant or award +50,000 266,159
2023-03-31 Duran Felipe Chief Financial Officer Grant or award +37,500 39,633
2023-03-23 Brenner Martin See Remarks Sale −5,213 $2.13 $11K 216,159
2023-02-21 Brenner Martin See Remarks Sale −3,976 $1.77 $7K 221,372
2023-01-20 Brenner Martin Interim CEO and CSO Grant or award +130,000 225,348
2022-11-11 Brenner Martin Chief Scientific Officer Grant or award +95,348 95,348
2022-11-11 Lutz Robert Matthew See Remarks Grant or award +100,057 102,165
2022-09-08 Isett Thomas Francis 3rd CEO and Executive Chairman Grant or award · Stock Option (right to buy) +2,000,000 2,000,000
2022-08-29 Lutz Robert Matthew See Remark Grant or award · Stock Option (right to buy) +400,000 400,000
2022-08-29 Brenner Martin Chief Scientific Officer Grant or award · Stock Option (right to buy) +700,000 700,000
2022-03-10 Lutz Robert Matthew See Remarks Sale −24,625 $0.35 $9K 207,375
2021-12-09 Clark William D Director Grant or award · Stock Option (right to buy) +109,000 109,000
2021-12-09 Schimmelpennink Evert B. Director Grant or award · Stock Option (right to buy) +109,000 109,000
2021-12-09 Kropotova Alexandra Director Grant or award · Stock Option (right to buy) +109,000 109,000
2021-12-09 Armstrong Linda Washington Director Grant or award · Stock Option (right to buy) +109,000 109,000
2021-12-09 Sender Gary Director Grant or award · Stock Option (right to buy) +109,000 109,000
2021-12-09 GENERAL HILL (Ret) JAMES T. Director Grant or award · Stock Option (right to buy) +109,000 109,000
2021-12-09 MCKEY JOHN D JR Director Grant or award · Stock Option (right to buy) +109,000 109,000
2021-12-09 Chang Glenn Director Grant or award · Stock Option (right to buy) +109,000 109,000

Page 4 of 7 · 126 trades